Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Farmacotherapie bij diabetische perifere neuropathie: een systematische review
jul 2017 | Diabetes